ATM is a key driver of NF-κB-dependent DNA-damage-induced senescence, stem cell dysfunction and aging

Jing Zhao,Lei Zhang,Aiping Lu,Yingchao Han,Debora Colangelo,Christina Bukata,Alex Scibetta,Matthew J Yousefzadeh,Xuesen Li,Aditi U Gurkar,Sara J McGowan,Luise Angelini,Ryan O'Kelly,Hongshuai Li,Lana Corbo,Tokio Sano,Heather Nick,Enrico Pola,Smitha P S Pilla,Warren C Ladiges,Nam Vo,Johnny Huard,Laura J Niedernhofer,Paul D Robbins,Matthew J. Yousefzadeh,Aditi U. Gurkar,Sara J. McGowan,Ryan O’Kelly,Smitha P.S. Pilla,Warren C. Ladiges,Laura J. Niedernhofer,Paul D. Robbins
DOI: https://doi.org/10.18632/aging.102863
2020-03-22
Aging
Abstract:NF-κB is a transcription factor activated in response to inflammatory, genotoxic and oxidative stress and important for driving senescence and aging. Ataxia-telangiectasia mutated (ATM) kinase, a core component of DNA damage response signaling, activates NF-κB in response to genotoxic and oxidative stress via post-translational modifications. Here we demonstrate that ATM is activated in senescent cells in culture and murine tissues from <i>Ercc1</i>-deficient mouse models of accelerated aging, as well as naturally aged mice. Genetic and pharmacologic inhibition of ATM reduced activation of NF-κB and markers of senescence and the senescence-associated secretory phenotype (SASP) in senescent <i>Ercc1<sup>-/-</sup></i> MEFs. <i>Ercc1<sup>-/Δ</sup></i> mice heterozygous for <i>Atm</i> have reduced NF-κB activity and cellular senescence, improved function of muscle-derived stem/progenetor cells (MDSPCs) and extended healthspan with reduced age-related pathology especially age-related bone and intervertebral disc pathologies. In addition, treatment of <i>Ercc1</i><sup>-/∆</sup> mice with the ATM inhibitor KU-55933 suppressed markers of senescence and SASP. Taken together, these results demonstrate that the ATM kinase is a major mediator of DNA damage-induced, NF-κB-mediated cellular senescence, stem cell dysfunction and aging and thus represents a therapeutic target to slow the progression of aging.
What problem does this paper attempt to address?